BICYCLE THERAPEUTICS PLC's ticker is BCYC and the CUSIP is 088786108. A total of 83 filers reported holding BICYCLE THERAPEUTICS PLC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $126,487 | -24.1% | 6,296 | -3.6% | 0.00% | – |
| Q2 2023 | $166,697 | +32.4% | 6,532 | +10.4% | 0.00% | – |
| Q1 2023 | $125,897 | -22.8% | 5,919 | +7.4% | 0.00% | – |
| Q4 2022 | $163,184 | -23.0% | 5,513 | -39.6% | 0.00% | – |
| Q3 2022 | $212,000 | -26.9% | 9,126 | -47.2% | 0.00% | – |
| Q2 2022 | $290,000 | +113.2% | 17,297 | +456.2% | 0.00% | – |
| Q1 2022 | $136,000 | -11.1% | 3,110 | +23.2% | 0.00% | – |
| Q4 2021 | $153,000 | +70.0% | 2,524 | +17.1% | 0.00% | – |
| Q3 2021 | $90,000 | +26.8% | 2,156 | -7.5% | 0.00% | – |
| Q2 2021 | $71,000 | +129.0% | 2,332 | +119.4% | 0.00% | – |
| Q1 2021 | $31,000 | +675.0% | 1,063 | +392.1% | 0.00% | – |
| Q4 2020 | $4,000 | – | 216 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 3,642,307 | $73,173,948 | 4.96% |
| Sio Capital Management, LLC | 796,933 | $16,010,384 | 4.96% |
| First Light Asset Management, LLC | 2,070,853 | $41,603,437 | 3.95% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,281,820 | $25,751,764 | 3.60% |
| Deep Track Capital, LP | 3,490,506 | $70,124,266 | 2.71% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,010,976 | $20,310,508 | 1.10% |
| HighVista Strategies LLC | 92,434 | $1,856,999 | 0.86% |
| BRAIDWELL LP | 1,289,872 | $25,913,528 | 0.82% |
| DAFNA Capital Management LLC | 122,200 | $2,454,998 | 0.76% |
| Soleus Capital Management, L.P. | 391,800 | $7,871,262 | 0.73% |